Sinovac Biotech is starting Phase III trials of its potential COVID-19 vaccine following a fast-track approval for the trials by Brazilian regulators last week. The study, done in partnership with Brazilian vaccine producer Instituto Butantan, will recruit nearly 9,000 healthcare professionals working in COVID-19-specialized facilities and start this month.